1.Hypogonadism and erectile dysfunction: an overview.
Nilgun GURBUZ ; Elnur MAMMADOV ; Mustafa Faruk USTA
Asian Journal of Andrology 2008;10(1):36-43
In humans androgen decline is presented as a clinical picture which includes decreased sexual interest, diminished erectile capacity, delayed or absent orgasms and reduced sexual pleasure. Additionally, changes in mood, diminished well being, fatigue, depression and irritability are also associated with androgen insufficiency. The critical role of androgens on the development, growth, and maintenance of the penis has been widely accepted. Although, the exact effect of androgens on erectile physiology still remains undetermined, recent experimental studies have broaden our understanding about the relationship between androgens and erectile function. Preclinical studies showed that androgen deprivation leads to penile tissue atrophy and alterations in the nerve structures of the penis. Furthermore, androgen deprivation caused to accumulation of fat containing cells and decreased protein expression of endothelial and neuronal nitric oxide synthases (eNOS and nNOS), and phosphodiesterase type-5 (PDE-5), which play crucial role in normal erectile physiology. On the light of the recent literature, we aimed to present the direct effect of androgens on the structures, development and maintenance of penile tissue and erectile physiology as well. Furthermore, according to the clinical studies we conclude the aetiology, pathophysiology, prevalence, diagnosis and treatment options of hypogonadism in aging men.
Aging
;
Androgens
;
physiology
;
Erectile Dysfunction
;
Humans
;
Hypogonadism
;
diagnosis
;
etiology
;
therapy
;
Male
;
Testosterone
;
therapeutic use
2.Usefulness of In Vivo and In Vitro Diagnostic Tests in the Diagnosis of Hypersensitivity Reactions to Quinolones and in the Evaluation of Cross-Reactivity: A Comprehensive Study Including the Latest Quinolone Gemifloxacin.
Semra DEMIR ; Asli GELINCIK ; Nilgun AKDENIZ ; Esin AKTAS-CETIN ; Muge OLGAC ; Derya UNAL ; Belkis ERTEK ; Raif COSKUN ; Bahattin COLAKOĞLU ; Gunnur DENIZ ; Suna BUYUKOZTURK
Allergy, Asthma & Immunology Research 2017;9(4):347-359
PURPOSE: Reports evaluating diagnosis and cross reactivity of quinolone hypersensitivity have revealed contradictory results. Furthermore, there are no reports investigating the cross-reactivity between gemifloxacin (GFX) and the others. We aimed to detect the usefulness of diagnostic tests of hypersensitivity reactions to quinolones and to evaluate the cross reactivity between different quinolones including the latest quinolone GFX. METHODS: We studied 54 patients (mean age 42.31±10.39 years; 47 female) with 57 hypersensitivity reactions due to different quinolones and 10 nonatopic quinolone tolerable control subjects. A detailed clinical history, skin test (ST), and single-blind placebo-controlled drug provocation test (SBPCDPT), as well as basophil activation test (BAT) and lymphocyte transformation test (LTT) were performed with the culprit and alternative quinolones including ciprofloxacin (CFX), moxifloxacin (MFX), levofloxacin (LFX), ofloxacin (OFX), and GFX. RESULTS: The majority (75.9%) of the patients reported immediate type reactions to various quinolones. The most common culprit drug was CFX (52.6%) and the most common reaction type was urticaria (26.3%). A quarter of the patients (24.1%) reacted to SBPCDPTs, although their STs were negative; while false ST positivity was 3.5% and ST/SBPCDPTs concordance was only 1.8%. Both BAT and LTT were not found useful in quinolone hypersensitivity. Cross-reactivity was primarily observed between LFX and OFX (50.0%), whereas it was the least between MFX and the others, and in GFX hypersensitive patients the degree of cross-reactivity to the other quinolones was 16.7%. CONCLUSIONS: These results suggest that STs, BAT, and LTT are not supportive in the diagnosis of a hypersensitivity reaction to quinolone as well as in the prediction of cross-reactivity. Drug provocation tests (DPTs) are necessary to identify both culprit and alternative quinolones.
Basophils
;
Ciprofloxacin
;
Diagnosis*
;
Diagnostic Tests, Routine*
;
Humans
;
Hypersensitivity*
;
In Vitro Techniques*
;
Levofloxacin
;
Lymphocyte Activation
;
Ofloxacin
;
Quinolones*
;
Skin Tests
;
Urticaria
3.An unusual dual hypersensitivity reaction to moxifloxacin in a patient
Semra DEMIR ; Derya UNAL ; Muge OLGAC ; Nilgun AKDENIZ ; Esin AKTAS-CETIN ; Asli GELINCIK ; Bahauddin COLAKOGLU ; Suna BUYUKOZTURK
Asia Pacific Allergy 2018;8(3):e26-
Both immediate and nonimmediate type hypersensitivity reactions (HRs) with a single dose of quinolone in the same patient have not been previously reported. A 47-year-old female patient referred to us because of the history of a nonimmediate type HR to radio contrast agent and immediate type HR to clarithromycin. She experienced anaphylaxis in minutes after the second dose of 50 mg when she was provocated with moxifloxacin. She was treated immediately with epinephrine, fluid replacement and methylprednisole and pheniramine. On the following day she came with macular eruptions, and she was treated with methylprednisolone. The positive patch test performed with moxifloxacin as well as the lymphocyte transformation test proved the T-cell mediated HR. In order to prove the immediate type HR, basophil activation test was performed but was found negative. This case report presents for the first time the 2 different types of HRs in a patient with a test dose of quinolone.
Anaphylaxis
;
Basophils
;
Clarithromycin
;
Epinephrine
;
Female
;
Humans
;
Hypersensitivity
;
Lymphocyte Activation
;
Methylprednisolone
;
Middle Aged
;
Patch Tests
;
Pheniramine
;
T-Lymphocytes